XDCEXPLORER SHANGHAI CO LTD has a total of 22 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are DENMEADE SAMUEL R, ALTAREX MEDICAL CORP and BIOMAY PROD & HANDEL.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 4 | |
#4 | Taiwan | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Heterocyclic compounds | |
#7 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Liu Lile | 10 |
#2 | Zhang Ying | 10 |
#3 | Hu Yonghan | 7 |
#4 | Wang Yan | 7 |
#5 | Angell Yvonne | 7 |
#6 | Wu Yun | 7 |
#7 | Zhang Yu | 5 |
#8 | Gong Shiyong | 5 |
#9 | Sun Xiaolan | 5 |
#10 | Liu Siqi | 4 |
Publication | Filing date | Title |
---|---|---|
WO2021027851A1 | Trop2 antibody, preparation method therefor, and conjugate and use thereof | |
WO2019114804A1 | Egfrviii antibody and conjugate, and preparation method and use thereof | |
TW201906856A | Peptide compound, application thereof and composition containing the same | |
WO2018103739A1 | Antibody-drug conjugate, preparation method, intermediate, pharmaceutical composition and use | |
EP3308801A1 | Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof |